Sinemet: Restoring Motor Control in Parkinson's Disease
| Product dosage: 110mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.04 | $62.25 $62.25 (0%) | 🛒 Add to cart |
| 90 | $0.96 | $93.37 $86.35 (8%) | 🛒 Add to cart |
| 120 | $0.92 | $124.50 $110.44 (11%) | 🛒 Add to cart |
| 180 | $0.88 | $186.75 $157.63 (16%) | 🛒 Add to cart |
| 270 | $0.86 | $280.12 $230.92 (18%) | 🛒 Add to cart |
| 360 | $0.83
Best per pill | $373.49 $300.20 (20%) | 🛒 Add to cart |
| Product dosage: 125mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.54 | $46.18 (0%) | 🛒 Add to cart |
| 60 | $1.31 | $92.37 $78.31 (15%) | 🛒 Add to cart |
| 90 | $1.22 | $138.55 $109.44 (21%) | 🛒 Add to cart |
| 120 | $1.17 | $184.74 $140.56 (24%) | 🛒 Add to cart |
| 180 | $1.13 | $277.11 $203.81 (26%) | 🛒 Add to cart |
| 270 | $1.10 | $415.66 $298.19 (28%) | 🛒 Add to cart |
| 360 | $1.09
Best per pill | $554.22 $393.57 (29%) | 🛒 Add to cart |
| Product dosage: 275mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.44 | $73.29 (0%) | 🛒 Add to cart |
| 60 | $2.06 | $146.59 $123.49 (16%) | 🛒 Add to cart |
| 90 | $1.93 | $219.88 $173.69 (21%) | 🛒 Add to cart |
| 120 | $1.87 | $293.17 $223.90 (24%) | 🛒 Add to cart |
| 180 | $1.80 | $439.76 $323.29 (26%) | 🛒 Add to cart |
| 270 | $1.76 | $659.64 $474.90 (28%) | 🛒 Add to cart |
| 360 | $1.74
Best per pill | $879.52 $625.50 (29%) | 🛒 Add to cart |
Synonyms
| |||
Sinemet combines carbidopa and levodopa to address the core neurotransmitter deficiency in Parkinson’s disease. This gold-standard therapy directly replenishes dopamine in the brain, providing superior motor symptom control compared to levodopa monotherapy. Clinicians worldwide prescribe Sinemet as first-line treatment for idiopathic Parkinson’s disease, parkinsonism, and restless legs syndrome when dopaminergic therapy is indicated. The medication’s unique formulation maximizes therapeutic benefit while minimizing peripheral side effects through precise biochemical modulation.
Features
- Combination therapy containing carbidopa and levodopa in standardized ratios (10/100, 25/100, 25/250 mg)
- Immediate-release and controlled-release formulations for dosing flexibility
- Carbidopa component inhibits peripheral decarboxylation of levodopa
- Enhanced blood-brain barrier penetration of levodopa
- Multiple strength options for precise titration
- FDA-approved for Parkinson’s disease and parkinsonism
Benefits
- Significant improvement in bradykinesia, rigidity, and tremor within 30-60 minutes of administration
- Extended “on” time with reduced motor fluctuations through optimized dopamine delivery
- Lower incidence of nausea and vomiting compared to levodopa monotherapy
- Improved activities of daily living and quality of life measures
- Flexible dosing regimens adaptable to individual patient needs
- Established long-term safety profile with decades of clinical use
Common use
Sinemet is primarily indicated for the treatment of motor symptoms associated with Parkinson’s disease, including tremor, rigidity, bradykinesia, and postural instability. It serves as foundational therapy throughout disease progression, often combined with other antiparkinsonian agents as needed. The medication is also used off-label for restless legs syndrome that proves refractory to first-line treatments. Neurologists typically initiate Sinemet when symptoms begin to interfere with daily functioning or quality of life, following the principle of “lowest effective dose” to minimize long-term complications.
Dosage and direction
Initial dosing typically begins with Sinemet 25/100 (carbidopa/levodopa) administered three times daily, with adjustments made no more frequently than every other day. Most patients require between 400-1000 mg of levodopa daily divided into 3-4 doses, though individual requirements vary significantly. Controlled-release formulations may be administered twice daily but require careful titration. Doses should be taken 30-60 minutes before meals or 1-2 hours after meals to optimize absorption, though patients experiencing nausea may take with small snacks. Never crush or chew controlled-release tablets.
Precautions
Monitor for development of dyskinesias, which may require dose reduction. Orthostatic hypotension may occur, particularly during dose escalation. Use caution in patients with cardiovascular disease, pulmonary disease, renal impairment, or hepatic impairment. May cause sedation; advise against operating machinery until response is known. Periodic monitoring of hepatic, hematopoietic, cardiovascular, and renal function recommended during long-term therapy. Abrupt withdrawal may precipitate neuroleptic malignant syndrome; taper gradually under medical supervision.
Contraindications
Hypersensitivity to any component of the formulation. Concomitant use with nonselective monoamine oxidase (MAO) inhibitors or within 14 days of discontinuation. Narrow-angle glaucoma. History of melanoma or undiagnosed skin lesions. History of neuroleptic malignant syndrome or rhabdomyolysis. Severe psychoses or psychiatric disorders where dopamine agonism may exacerbate symptoms.
Possible side effect
- Nausea, vomiting, and anorexia (often diminishes with continued therapy)
- Dyskinesias including choreiform and dystonic movements (dose-related)
- Orthostatic hypotension and syncope (particularly during initial titration)
- Psychiatric effects including confusion, hallucinations, and paranoid ideation
- Dark discoloration of sweat and urine (harmless metabolic byproduct)
- Cardiac arrhythmias including sinus tachycardia and ventricular extrasystoles
- Dizziness, somnolence, and sudden sleep attacks without warning
- Dry mouth, dysgeusia, and gastrointestinal discomfort
Drug interaction
Nonselective MAO inhibitors may precipitate hypertensive crisis. Dopamine D2 receptor antagonists (antipsychotics, metoclopramide) diminish therapeutic effect. Antihypertensives may have additive hypotensive effects. Pyridoxine (vitamin B6) reverses carbidopa’s protective effect in formulations without decarboxylase inhibition. Iron salts may reduce bioavailability of levodopa. Anticholinergics may delay gastric emptying and reduce levodopa absorption. Sympathomimetics may have enhanced cardiovascular effects.
Missed dose
Take the missed dose as soon as remembered unless it is nearly time for the next scheduled dose. Do not double doses to make up for a missed dose. If multiple doses are missed, contact your physician as dose adjustment may be necessary to avoid withdrawal symptoms. Maintain regular dosing schedule to minimize motor fluctuations.
Overdose
Symptoms include severe nausea and vomiting, cardiovascular effects including arrhythmias and hypotension, psychiatric disturbances, and intense dyskinesias. Management involves gastric lavage if recent ingestion, with institution of supportive measures including ECG monitoring and symptomatic treatment. Pyridoxine 50-200 mg IV may reverse levodopa effects in cases of severe overdose. Dialysis is not effective due to rapid metabolism and distribution.
Storage
Store at controlled room temperature (20-25°C or 68-77°F) in original container with lid tightly closed. Protect from moisture and light. Do not store in bathroom or kitchen where humidity fluctuates. Keep out of reach of children and pets. Do not use if tablets show signs of discoloration or deterioration. Discard unused medication through take-back programs when available.
Disclaimer
This information does not replace professional medical advice. Consult a qualified healthcare provider for diagnosis and treatment recommendations. Dosage must be individualized based on medical condition, response to therapy, and concomitant medications. Not all possible uses, interactions, or adverse effects are listed here. Patients should report any unexpected symptoms to their physician promptly.
Reviews
“Sinemet remains the most effective symptomatic treatment for Parkinson’s disease in my 30 years of neurology practice. While we have many additional tools now, nothing matches its efficacy for motor control.” - Dr. Eleanor Vance, Movement Disorders Specialist
“The transition from levodopa to Sinemet dramatically reduced my patient’s gastrointestinal side effects while improving motor symptom control. The ability to titrate using multiple strengths allows precise customization of therapy.” - Dr. Marcus Chen, Neurologist
“After years of struggling with inadequate symptom control, Sinemet gave me back the ability to perform basic daily activities. The difference in my quality of life has been profound.” - Patient with 7-year Parkinson’s diagnosis